Mark G. Carter, Ph.D. - Publications
Affiliations: | 2000 | Johns Hopkins University, Baltimore, MD |
Area:
GeneticsYear | Citation | Score | |||
---|---|---|---|---|---|
2007 | Yang X, Carter MG. Transgenic animal bioreactors: a new line of defense against chemical weapons? Proceedings of the National Academy of Sciences of the United States of America. 104: 13859-60. PMID 17715298 DOI: 10.1073/Pnas.0706163104 | 0.303 | |||
2005 | Sakatani T, Kaneda A, Iacobuzio-Donahue CA, Carter MG, de Boom Witzel S, Okano H, Ko MS, Ohlsson R, Longo DL, Feinberg AP. Loss of imprinting of Igf2 alters intestinal maturation and tumorigenesis in mice. Science (New York, N.Y.). 307: 1976-8. PMID 15731405 DOI: 10.1126/Science.1108080 | 0.417 | |||
2004 | Hamatani T, Falco G, Carter MG, Akutsu H, Stagg CA, Sharov AA, Dudekula DB, VanBuren V, Ko MS. Age-associated alteration of gene expression patterns in mouse oocytes. Human Molecular Genetics. 13: 2263-78. PMID 15317747 DOI: 10.1093/Hmg/Ddh241 | 0.327 | |||
2003 | Chen WY, Zeng X, Carter MG, Morrell CN, Chiu Yen RW, Esteller M, Watkins DN, Herman JG, Mankowski JL, Baylin SB. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nature Genetics. 33: 197-202. PMID 12539045 DOI: 10.1038/Ng1077 | 0.437 | |||
2000 | Carter MG, Johns MA, Zeng X, Zhou L, Zink MC, Mankowski JL, Donovan DM, Baylin SB. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Human Molecular Genetics. 9: 413-9. PMID 10655551 DOI: 10.1093/Hmg/9.3.413 | 0.44 | |||
Show low-probability matches. |